Viewing Study NCT02691793


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-01-01 @ 9:32 AM
Study NCT ID: NCT02691793
Status: COMPLETED
Last Update Posted: 2022-06-15
First Post: 2016-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors
Sponsor: Samsung Medical Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-11-20
Start Date Type: ACTUAL
Primary Completion Date: 2019-08-30
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-19
Completion Date Type: ACTUAL
First Submit Date: 2016-02-22
First Submit QC Date: None
Study First Post Date: 2016-02-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-13
Last Update Post Date: 2022-06-15
Last Update Post Date Type: ACTUAL